share_log

Entrada Therapeutics | 10-K/A: Annual report (Amendment)

SEC announcement ·  Aug 8, 2023 07:23
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more